← Eichor
Study identifier: NCT05055635 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)

Condition: Anal Cancer · Recurrent Anal Cancer  ·  Sponsor: University of Aarhus

PhasePhase 2
Planned participants55
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This protocol aims to determine toxicity and efficacy of re-irradiation for patients with recurrences from anal cancers with dose-escalated pencil beam proton therapy either pre-operative for marginally resectable recurrences or as a definitive treatment strategy (un-resectable, operation declined etc.). The over-all aim is to improve local tumor control with acceptable side effects.

This description comes directly from the study's public registry record.

Talk to the study team

Camilla Kronborg, MD, PhD  ·  +45 78 45 00 00  ·  camkro@rm.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Danish Centre for Particle TherapyAarhus N, Aarhus, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05055635